Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2022 Earnings Call Transcript

Operator: Good morning and welcome to Editas Medicine's Fourth Quarter and Full-year 2022 Conference Call. All participants are now in a listen-only mode.

Related Keywords

Hungary ,Hungarian ,Michelle Robertson ,Baisong Mei ,Samantha Semenkow ,Gilmore Oneill ,Joon Lee ,Bruce Eaton ,Ron Moldaver ,Most Valuable Hungarian Companies ,National Cancer Institute On Unsplash ,Editas Medicine Inc ,Nasdaq ,Editas Medicine ,Call Transcript February ,Fourth Quarter ,Investor Relations ,Forward Looking Statements ,Safe Harbor ,Private Securities Litigation Reform Act ,Risk Factors ,Edita Executive ,Chief Medical Officer ,Chief Financial ,Dependent Beta Thalassemia ,Shoreline Biosciences ,Leadership Chief Technology Officer ,Chief Business Officer ,National Cancer Institute ,Chief Medical ,Mean Corpuscular ,Chief Financial Officer ,Profitable Pharmaceutical Stocks Now ,Valuable Hungarian ,Chief Technology Officer ,